Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine

CAI Yiqing; JIN Xinyan; LIU Jianping

doi:10.13288/j.11-2166/r.2023.08.009

您当前的位置：

首页 >

文章列表页 >

Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine

更新时间：2023-04-14

- Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine
- Journal of Traditional Chinese Medicine Vol. 64, Issue 8, Pages: 799-804(2023)
- 作者机构：
  
  北京中医药大学循证医学中心，北京市朝阳区北三环东路11号，100029
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2023.08.009
  CLC：
- Received：10 October 2022，
  
  Revised：2023-01-30，
  
  Published：17 April 2023
- 稿件说明：
移动端阅览
蔡祎晴,金信妍,刘建平.回顾性治疗结局研究设计及其在中医学领域的应用展望[J].中医杂志,2023,64(08):799-804.

CAI Yiqing,JIN Xinyan,LIU Jianping.Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2023,64(08):799-804.
蔡祎晴,金信妍,刘建平.回顾性治疗结局研究设计及其在中医学领域的应用展望[J].中医杂志,2023,64(08):799-804. DOI： 10.13288/j.11-2166/r.2023.08.009.

CAI Yiqing,JIN Xinyan,LIU Jianping.Design of Retrospective Treatment Outcome Research and Its Application in Traditional Chinese Medicine[J].Journal of Traditional Chinese Medicine,2023,64(08):799-804. DOI： 10.13288/j.11-2166/r.2023.08.009.

摘要

回顾性治疗结局（RTO）研究是一种通过回顾性问卷调查或访谈，对已经出现临床结局的某一特定人群在某一特定时期的暴露因素或接受的治疗措施进行资料收集，分析各暴露因素或治疗措施与疾病结局之间相关性的观察性研究。其可用于初步评估治疗措施对特定人群已出现的疾病结局的有效性和安全性，识别与疾病结局关联较强的治疗措施，从而为后续的前瞻性临床试验提供线索。系统介绍RTO的概念、起源与方法学设计要点，对比RTO与其他观察性研究的异同，分析RTO的应用现状与展望、优势与局限性。在此基础上提出，在中医药领域可采用RTO研究筛选治疗某疾病的不同组方/配伍比例/剂量/剂型/给药方式的中药，初步评价中医特色疗法治未病的效果，遴选新发突发传染病的不同治疗方案等，以期为RTO研究在中医药领域的应用提供方法学参考。

Abstract

Retrospective treatment outcome （RTO） is a kind of observational study that retrospectively collects data about the exposure factors or the interventions over a period of time in certain people who have already had clinical outcomes through questionnaire survey or interview， and analyzes the correlation between exposure factors or interventions and disease outcomes. RTO can initially evaluate the effectiveness and safety of the interventions for the specific group of people， and identify the treatments with the highest association with disease outcomes， thereby providing clues and evidence for subsequent prospective clinical trials. This study systematically introduced the concept， origin and methodological items of RTO， compared the similarities and differences between RTO and other observational studies， described the application status and prospects， advantages and limitations of RTO. It is proposed that future applications of RTO in traditional Chinese medicine （TCM） include such as screening out the Chinese material medica with different prescriptions/ compatibility/ dosage/ preparations/ modes of administration， evaluating the effect of TCM-specific therapies when treating disease before it arises， selecting the varied treatment options for emergent and novel infectious diseases. All these provide methodological references for the application of RTO in conducting TCM researches.

关键词

Keywords

references

刘建平，高颖 . 中医临床真实世界研究［M］. 北京：中国中医药出版社， 2021 .

WILLCOX M ， GRAZ B ， FALQUET J ， et al . A “reverse pharmacology” approach for developing an anti-malarial phytomedicine ［J］. Malar J ， 2011 ， 10 （ Suppl 1 ）： S8 . doi： 10.1186/1475-2875-10-S1-S8 http://dx.doi.org/10.1186/1475-2875-10-S1-S8 .

LU CL ， ZHENG RX ， XUE X ， et al . Traditional Chinese medicine for COVID-19 pandemic and emerging challenges： an online cross-sectional survey in China ［J］. Integr Med Res ， 2021 ， 10 （ Suppl ）： 100798 .

李慧，黄哲 . 新药研发中体外遗传毒性试验风险故障树的构建及权重分析［J］. 中国新药杂志， 2015 ， 24 （ 8 ）： 849 - 856 .

NWAKA S ， RAMIREZ B ， BRUN R ， et al . Advancing drug innovation for neglected diseases-criteria for lead progression ［J］. PLoS Negl Trop Dis ， 2009 ， 3 ： e440 . doi： 10. 1371/journal.pntd.0000440 http://dx.doi.org/10.1371/journal.pntd.0000440 .

GRAZ B ， DIALLO D ， WILLCOX M ， et al . Screening of traditional herbal medicine： first， do a retrospective study， with correlation between diverse treatments used and reported patient outcome ［J］. J Ethnopharmacol ， 2005 ， 101 （ 1-3 ）： 338 - 339 .

JEREMY HOWICK . Oxford Centre for Evidence-Based Medicine： levels of evidence ［EB/OL］. （ 2009-03-01 ）［ 2023-01-10 ］. https：//www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford .

陈薇，陈可冀，刘建平 . 中医药真实世界研究证据的构成及分级标准建议［J］. 中国中西医结合杂志， 2021 ， 41 （ 5 ）： 608 - 611 .

GRAZ B ， ELISABETSKY E ， FALQUET J . Beyond the myth of expensive clinical study： assessment of traditional medicines ［J］. J Ethnopharmacol ， 2007 ， 113 （ 3 ）： 382 - 386 .

万霞，刘建平 . 临床研究中的样本量估算：（2）观察性研究［J］. 中医杂志， 2007 ， 48 （ 7 ）： 599 - 601 .

刘晓华，周倩，成守珍 . 横断面研究护理论文评价要点解读（二）［J］. 现代临床护理， 2019 ， 18 （ 7 ）： 78 - 83 .

MARCANO BELISARIO JS ， JAMSEK J ， HUCKVALE K ， et al . Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods ［J］. Cochrane Database Syst Rev ， 2015 ， 2015 （ 7 ）： MR000042 . doi： 10.1002/14651858.MR000042 http://dx.doi.org/10.1002/14651858.MR000042 .

熊中敏，郭怀宇，吴月欣 . 缺失数据处理方法研究综述［J］. 计算机工程与应用， 2021 ， 57 （ 14 ）： 27 - 38 .

卓琳，王胜锋，詹思延 . 横断面调查的论文报告规范［J］. 中国卫生监督杂志， 2017 ， 24 （ 3 ）： 210 - 216 .

GRAZ B ， WILLCOX M ， BERTHÉ D ， et al . Home treatments alone or mixed with modern treatments for malaria in Finkolo AC， South Mali： reported use， outcomes and changes over 10 years ［J］. Trans R Soc Trop Med Hyg ， 2015 ， 109 （ 3 ）： 209 - 213 .

GRAZ B ， KITALONG C ， YANO V . Traditional local medicines in the republic of Palau and non-communicable diseases （NCD）， signs of effectiveness ［J］. J Ethnopharmacol ， 2015 ， 161 ： 233 - 237 . doi： 10.1016/j.jep. 2014. 11. 047 http://dx.doi.org/10.1016/j.jep.2014.11.047 .

VON ELM E ， ALTMAN DG ， EGGER M ， et al . The Strengthening the Reporting of Observational Studies in Epidemiology （STROBE） statement： guidelines for reporting observational studies ［J］. Lancet ， 2007 ， 370 （ 9596 ）： 1453 - 1457 .

EYSENBACH G . Improving the quality of web surveys： the Checklist for Reporting Results of Internet E-Surveys （CHERRIES）［J］. J Med Internet Res ， 2004 ， 6 （ 3 ）： e34 . doi： 10.2196/jmir.6.3.e34 http://dx.doi.org/10.2196/jmir.6.3.e34 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advantages，Challenges，and Implementation Pathways of Natural Experiments in Evaluating the Efficacy of Traditional Chinese Medicine

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Identification and Control Strategies for Immortal Time Bias in Traditional Chinese Medicine Cohort Studies

Characteristics of Traditional Chinese Medicine Syndromes and Treatment Rules in Ulcerative Colitis Patients in Jiangsu Province：Based on Real-World Data

Related Author

LIU Rihe

LIU Tingxiu

LIU Kai

SUN Yuan

ZHANG Xiaohan

LIU Jianping

LIU Zhaolan

ZHOU Xianmei

Related Institution

Center for Evidence-Based Medicine，Hospital of Chengdu University of Traditional Chinese Medicine

Sichuan Provincial Center for Evidence-Based Chinese Medicine

Affiliated Hospital of Nanjing University of Chinese Medicine

Institute of Basic Research in clinical Medicine，China Academy of Chinese Medical Sciences

Data Center of Chinese Medicine，China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰